These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 15284314

  • 1. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
    Kim JJ, Leung GM, Woo PP, Goldie SJ.
    J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening.
    Bidus MA, Maxwell GL, Kulasingam S, Rose GS, Elkas JC, Chernofsky M, Myers ER.
    Obstet Gynecol; 2006 May; 107(5):997-1005. PubMed ID: 16648402
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.
    Chen MK, Hung HF, Duffy S, Yen AM, Chen HH.
    J Eval Clin Pract; 2011 Dec; 17(6):1050-8. PubMed ID: 21679279
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA.
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests.
    Kulasingam SL, Myers ER, Lawson HW, McConnell KJ, Kerlikowske K, Melnikow J, Washington AE, Sawaya GF.
    Obstet Gynecol; 2006 Feb; 107(2 Pt 1):321-8. PubMed ID: 16449119
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands.
    Coupé VM, de Melker HE, Snijders PJ, Meijer CJ, Berkhof J.
    Vaccine; 2009 Aug 13; 27(37):5111-9. PubMed ID: 19567242
    [Abstract] [Full Text] [Related]

  • 16. The cost-effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range?
    Anderson R, Haas M, Shanahan M.
    Aust N Z J Public Health; 2008 Feb 13; 32(1):43-52. PubMed ID: 18290913
    [Abstract] [Full Text] [Related]

  • 17. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
    Havrilesky LJ, Sanders GD, Kulasingam S, Myers ER.
    Gynecol Oncol; 2008 Nov 13; 111(2):179-87. PubMed ID: 18722004
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
    Sepúlveda C, Prado R.
    Cancer Detect Prev; 2005 Nov 13; 29(5):405-11. PubMed ID: 16188399
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.